Condition Lookup
Sub-Category:
Non-Alcoholic Fatty Liver Disease (NAFLD)
Number of Conditions: 1
Non-Alcoholic Steatohepatitis (NASH)
Specialty: Gastrointestinal
Category: Liver Disorders
Sub-category: Non-Alcoholic Fatty Liver Disease (NAFLD)
Symptoms:
fatigue; mild abdominal discomfort; enlarged liver (hepatomegaly); jaundice (in advanced cases); asymptomatic in early stages
Root Cause:
Fat accumulation in the liver causing inflammation and damage, not related to alcohol use.
How it's Diagnosed: videos
Liver function tests, imaging (ultrasound, CT, or MRI), and liver biopsy.
Treatment:
Lifestyle changes (weight loss, healthy diet, exercise), management of comorbidities (diabetes, dyslipidemia).
Medications:
Vitamin E (antioxidant for non-diabetic patients). Pioglitazone (insulin sensitizer, for patients with type 2 diabetes). Obeticholic acid (under study for reducing liver inflammation and fibrosis).
Prevalence:
How common the health condition is within a specific population.
Affects about 3–5% of the global population; more common in individuals with obesity or diabetes.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Obesity, type 2 diabetes, metabolic syndrome, dyslipidemia, sedentary lifestyle.
Prognosis:
The expected outcome or course of the condition over time.
Variable; can remain stable with lifestyle modifications or progress to cirrhosis and liver failure if untreated.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Cirrhosis, liver failure, hepatocellular carcinoma, cardiovascular disease.